Kyntra Bio, Inc. (KYNB) Earnings History
Profitable14 years of earnings data (2012–2025) · Positive TTM net income
Loading earnings history...
Kyntra Bio, Inc. (KYNB) Earnings Overview
As of November 18, 2026, Kyntra Bio, Inc. (KYNB) reported trailing twelve-month net income of $35M, reflecting +481.6% year-over-year growth. The company earned $8.61 per diluted share over the past four quarters, with a net profit margin of 2848.6%.
Looking at the long-term picture, KYNB's historical earnings data spans multiple years. The company achieved its highest annual net income of $183M in fiscal 2025, representing a new all-time high.
Kyntra Bio, Inc. maintains industry-leading profitability with a gross margin of 91.4%, operating margin of -712.7%, and net margin of 2848.6%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including AKBA (-$45M net income, -2.3% margin), PTCT (-$106M net income, 39.4% margin), RARE (-$524M net income, -85.4% margin), KYNB has outperformed on profitability metrics. Compare KYNB vs AKBA →
KYNB Earnings vs Peers
Earnings metrics vs comparable public companies
KYNB Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $183M | +485.6% | -$46M | $45.37 | 2848.6% | -712.7% |
| 2024 | -$48M | +83.3% | -$150M | $-11.89 | -160.6% | -507.8% |
| 2023 | -$284M | +3.2% | -$323M | $-73.03 | -607.3% | -689.5% |
| 2022 | -$294M | -1.3% | -$301M | $-78.45 | -208.7% | -213.9% |
| 2021 | -$290M | -53.2% | -$289M | $-78.51 | -123.3% | -122.6% |
| 2020 | -$189M | -145.9% | -$192M | $-2.11 | -107.4% | -108.8% |
| 2019 | -$77M | +10.9% | -$89M | $-0.89 | -30.0% | -34.8% |
| 2018 | -$86M | +31.5% | -$87M | $-1.03 | -40.6% | -40.7% |
| 2017 | -$126M | -104.6% | -$123M | $-1.73 | -100.4% | -97.6% |
| 2016 | -$62M | +28.1% | -$54M | $-0.98 | -34.3% | -29.9% |
| 2015 | -$86M | -44.2% | -$78M | $-1.42 | -47.4% | -42.9% |
| 2014 | -$60M | -298.2% | -$50M | $-1.04 | -43.2% | -36.4% |
| 2013 | -$15M | +54.1% | -$8M | $-0.32 | -14.6% | -7.8% |
| 2012 | -$33M | - | -$27M | $-2.47 | -49.4% | -41.3% |
Download Data
Export KYNB earnings history in CSV or JSON format
Free sign-in required to download data
KYNB Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
KYNB — Frequently Asked Questions
Quick answers to the most common questions about buying KYNB stock.
What is KYNB earnings per share (EPS)?
KYNB trailing twelve-month (TTM) diluted EPS is $8.61, reflecting +481.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Kyntra Bio, Inc.'s net income?
Kyntra Bio, Inc. (KYNB) trailing twelve-month net income is $35M as of 2025. Earnings grew +481.6% year-over-year.
Is KYNB profitable?
Yes, KYNB is profitable with a TTM net income of $35M and a net profit margin of +2848.6%.
What is KYNB's earnings growth rate?
KYNB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are KYNB's profit margins?
Kyntra Bio, Inc. net profit margin is +2848.6%, operating margin is -712.7%, and gross margin is +91.4%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +4099.5%.
Is KYNB growing earnings?
Yes, KYNB earnings are accelerating — EPS growth of +481.6% exceeds the 5-year CAGR of N/A. TTM net income reached $35M. Earnings momentum is strengthening.
What was KYNB's best earnings year?
Kyntra Bio, Inc.'s highest annual net income on record is $183M, achieved in fiscal year 2025. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were KYNB's earnings last quarter?
KYNB's most recent reported quarter was Q3 2026. Net income was $157000.00 with diluted EPS of $0.04. For a full breakdown of all quarters, see the quarterly earnings table on this page.